4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-25-003775
Chief Executive Officer sold 59,569 shares at an average $0.58 ($34,639)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2025-01-13 | Sale | −12,539 | $0.59 | $7,372 | 17,801 | D |
| Rawcliffe Adrian Chief Executive Officer | 2025-01-13 | Sale | −17,934 | $0.59 | $10,543 | 25,711 | D |
| Rawcliffe Adrian Chief Executive Officer | 2025-01-15 | Sale | −29,096 | $0.57 | $16,724 | 41,582 | D |
| Open-market sales · 59,569 sh · avg $0.58 · $34,639 | |||||||
Loading xslF345X05/tm253441-5_4seq1.xml…